SCYNEXIS
SCYX
$1.54
Share price
4.76%
Change (1 day)
-49.67%
Change (1 year)
Categories
EPS for SCYNEXIS (SCYX)
EPS in 2023 (TTM): $0.94
According to SCYNEXIS's latest financial reports the company's current EPS (TTM) is $0.94. In 2022 the company made an earnings per share (EPS) of -$1.39 a decrease over its 2021 EPS that were of -$1.25.
EPS history for SCYNEXIS from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $0.94 | -167.63% |
| 2022 | -$1.39 | 11.2% |
| 2021 | -$1.25 | -75.92% |
| 2020 | -$5.19 | -46.77% |
| 2019 | -$9.75 | 248.21% |
| 2018 | -$2.80 | -69.89% |
| 2017 | -$9.30 | -42.24% |
| 2016 | -$16.10 | -40.81% |
| 2015 | -$27.20 | 372.47% |
| 2014 | -$5.76 | -98.06% |
| 2013 | -$296.03 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Galmed Pharmaceuticals
GLMD | -$6.69 | -811.70% | 🇮🇱 Israel |
 Catalyst Pharmaceuticals CPRX | $1.10 | 17.02% | 🇺🇸 USA |
 Catalent CTLT | -$1.29 | -237.23% | 🇺🇸 USA |
 KemPharm KMPH | -$0.99 | -205.32% | 🇺🇸 USA |